WHY IT MATTERS: If Medicare begins covering cannabis-based medications, seniors who currently spend hundreds of dollars monthly out of pocket on cannabinoid therapies could see significant cost relief and improved access to physician-supervised treatment plans. CLINICAL OVERVIEW: The possibility of Medicare covering certain cannabis-based medications represents a significant shift in how the federal government treats cannabinoid therapeutics for older adults. From a clinical standpoint, this could dramatically improve access for seniors who currently pay entirely out of pocket for cannabis medicines, often on fixed incomes, while simultaneously catalyzing the rigorous research needed to establish evidence-based dosing protocols and safety profiles for this population.